Pharmaceuticals Subscribe

Nonalcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of a fatty, inflamed, and damaged liver. It resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. NASH is becoming […]

GlobalData’s clinical trial report, “Fungemia Global Clinical Trials Review, H2, 2013” provides data on the Fungemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fungemia. It includes an overview of the trial […]

GlobalData’s clinical trial report, “Blepharitis Global Clinical Trials Review, H2, 2013” provides data on the Blepharitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Blepharitis. It includes an overview of the trial […]

GlobalData’s clinical trial report, “Seborrhea Global Clinical Trials Review, H2, 2013” provides data on the Seborrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seborrhea. It includes an overview of the trial […]

Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around […]

The indispensable source of thousands of facts, figures and statistics for 67 pharmaceutical markets worldwide! The World Pharmaceutical Market Fact Book 2013 is the ideal companion in today’s challenging pharmaceutical market environment. The need to understand world pharmaceutical marketplaces, and […]

This study analyzes the world market for medical device packaging. It presents historical (2002, 2007, 2012) demand data and forecasts for 2017 and 2022 by type (e.g., trays, pouches, bags, blister and clamshell packs, boxes, specialty vials, labels, lidding, protective […]

Biologics are complex molecules manufactured through cell culture recombinant DNA technology. Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating conditions such as cancer and autoimmunity. Also known as follow-on biologics or subsequent entry biologics (SEBs), biosimilars […]

Biosimilars: another milestone passed At the end of June 2013, the European Medicines Agency’s Committee for Medical Products for Human Use issued a positive opinion for the first biosimilar version of Johnson & Johnson’s infliximab for the treatment of rheumatoid […]

The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines. In China, vaccines are generally divided into Vaccine […]